Other languages InspireMD, Inc.

Equities

NSPR

US45779A8466

Market Closed - Nasdaq Other stock markets 16:30:00 2024-05-17 EDT			5-day change	1st Jan Change
2.3 ^USD	0.00%		+2.91%	-18.15%

05-14	Transcript : InspireMD, Inc., Q1 2024 Earnings Call, May 14, 2024
05-14	Earnings Flash (NSPR) INSPIREMD Posts Q1 Revenue $1.5M, vs. Street Est of $1.9M	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

InspireMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-05
InspireMD Gets CE Mark Recertification From the European Union	01-31
InspireMD, Inc. Announces Appointment of Pete Ligotti as Executive Vice President and General Manager of North America	01-03
InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions	11-27
InspireMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-06
Inspiremd, Inc. Presents Positive 30-Day Follow-Up Results from the C-Guard®? U.S. Investigational Device Exemption Clinical Trial	11-01
InspireMD, Inc. Supports CMS? Final National Coverage Determination Expanding Coverage of Carotid Stenting to Include Both Asymptomatic and Standard Risk Patients	23-10-12
InspireMD, Inc. Announces Management Appointments	23-10-03
InspireMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07
InspireMD, Inc. Announces Completion of Enrollment in C-Guardians U.S. Investigational Device Exemption Clinical Trial	23-06-26
Insider Buy: Inspiremd	23-05-16
Insider Buy: Inspiremd	23-05-16
Insider Buy: Inspiremd	23-05-16
Insider Buy: Inspiremd	23-05-16
InspireMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
InspireMD to Raise Funds From Placement With Healthcare Investors; Shares Rise	23-05-15
InspireMD, Inc. Announces Successful First-In-Human Procedure Utilizing CGuard Prime, its Next Generation Carotid Artery Stent Platform	23-05-01
InspireMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30
InspireMD, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-30
InspireMD, Inc. Auditor Raises 'Going Concern' Doubt	23-03-29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages InspireMD, Inc.

Equities

NSPR

US45779A8466

Other languages

Filters